Salarius: Q1 Earnings Snapshot

·1 min read

HOUSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $1.9 million in its first quarter.

On a per-share basis, the Houston-based company said it had a loss of 6 cents.

The biotech drug developer posted revenue of $1.3 million in the period.

The company's shares closed at $1.08. A year ago, they were trading at $1.75.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SLRX at

The Associated Press

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting